Department of Ultrasound, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of General Surgery, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Invest Surg. 2022 Jul;35(7):1519-1525. doi: 10.1080/08941939.2022.2075494. Epub 2022 May 24.
To identify candidate factors for predicting high-volume lateral lymph node metastasis (LLNM) in papillary thyroid microcarcinoma (PTMC).
We retrospectively studied 2981 patients with PTMC who underwent thyroidectomy from 2013 to 2016. LLNM was identified by histopathology. Patients with different LLNM statuses were compared according to clinical, sonographic and pathological parameters. A multivariate logistic model was established to predict high-volume LLNM (number of metastatic lymph nodes >5).
High-volume LLNM of PTMC was independently associated with age < 40 years (OR = 1.791, P = 0.023), male sex (OR = 2.401, = 0.001), tumor size > 0.5 cm (OR = 4.839, < 0.001), extrathyroidal extension (OR = 2.097, = 0.007) and microcalcification (OR = 2.894, = 0.002). These five factors were incorporated together to develop a multivariate analysis, which showed good predictive ability (AUC = 0.78, 95% CI 0.72-0.83), with a sensitivity of 80.0% and a specificity of 61.4%. Moreover, more level II or V lateral regions were involved in patients with high-volume LLNM than in those with small-volume LLNM (69.2% vs. 25.0%, < 0.001; 10.8% vs. 4.7%, < 0.001).
Multilevel LLNM tended to be more common in patients with PTMC who had high-volume LLNM. The high-volume LLNM rates of patients with PTMC with age < 40 years, male sex, tumor size > 0.5 cm, extrathyroidal extension and microcalcification were relatively higher than those without. These findings may be useful for identifying patients at higher high-volume LLNM risk who may require more aggressive treatment or intensive follow-up management.
确定预测甲状腺乳头状微小癌(PTMC)高容量侧颈部淋巴结转移(LLNM)的候选因素。
我们回顾性研究了 2013 年至 2016 年间接受甲状腺切除术的 2981 例 PTMC 患者。通过组织病理学确定 LLNM。根据临床、超声和病理参数比较不同 LLNM 状态的患者。建立多变量逻辑模型预测高容量 LLNM(转移淋巴结数>5 个)。
PTMC 高容量 LLNM 与年龄<40 岁(OR=1.791,P=0.023)、男性(OR=2.401,P=0.001)、肿瘤大小>0.5cm(OR=4.839,P<0.001)、甲状腺外侵犯(OR=2.097,P=0.007)和微钙化(OR=2.894,P=0.002)独立相关。将这五个因素纳入多变量分析,结果显示具有良好的预测能力(AUC=0.78,95%CI 0.72-0.83),敏感性为 80.0%,特异性为 61.4%。此外,高容量 LLNM 患者比小容量 LLNM 患者涉及更多的 II 级或 V 级侧区(69.2%比 25.0%,P<0.001;10.8%比 4.7%,P<0.001)。
在有高容量 LLNM 的 PTMC 患者中,多水平 LLNM 更为常见。年龄<40 岁、男性、肿瘤大小>0.5cm、甲状腺外侵犯和微钙化的 PTMC 患者高容量 LLNM 发生率相对较高。这些发现可能有助于识别具有更高高容量 LLNM 风险的患者,这些患者可能需要更积极的治疗或强化随访管理。